Multiple Sclerosis: Treatment and Care Considerations
It is estimated that there are more than 2.8 million people worldwide living with multiple sclerosis (MS). In the United States, there are almost 1 million people living with the disease (National Multiple Sclerosis Society [NMSS], 2020). MS is a chronic, progressive autoimmune disease of the central nervous system (CNS) caused by damage to the protective myelin sheath covering neurons. MS lesions, or plaques, disrupt electrical impulses from neurons in the CNS to muscles that can affect mobility, elimination, energy, vision, and other functions (DynaMed, 2022).
It is estimated that there are more than 2.8 million people worldwide living with multiple sclerosis (MS). In the United States, there are almost 1 million people living with the disease (National Multiple Sclerosis Society [NMSS], 2020). MS is a chronic, progressive autoimmune disease of the central nervous system (CNS) caused by damage to the protective myelin sheath covering neurons. MS lesions, or plaques, disrupt electrical impulses from neurons in the CNS to muscles that can affect mobility, elimination, energy, vision, and other functions (DynaMed, 2022).
Accreditation Council for Continuing Medical Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Relias LLC designates this enduring activity for a maximum of 1.00 AMA PRA category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 1.00 Nursing Contact Hours after successfully completing this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
Council on Optometric Practitioner Education
As a Jointly Accredited organization, Relias LLC is approved to offer co-sponsored COPE CE credit by the Council on Optometric Practitioner Education (COPE). COPE is an associate member of Joint Accreditation for Interprofessional Continuing Education.
COPE Course ID number: 88849-SD
COPE Activity ID number: 127427
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
Florida Board of Nursing
Florida Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Kentucky Board of Nursing
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Mississippi Board of Nursing
Mississippi Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
North Dakota Board of Nursing
North Dakota Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
South Carolina Board of Nursing
South Carolina Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
West Virginia Board of Registered Nursing
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Recall the overarching disease pathophysiology and main symptoms with discernable interventions of MS.
Identify the disease classifications and the diagnostic algorithm, including the McDonald Criteria for MS.
Review therapeutic approaches for treating the underlying disease of MS.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Overview
Meet Sarah
Background
Epidemiology and Quick Facts
Current Problem
Gap Needs Analysis
Section 3: Pathophysiology
Overview
Immune-Inflammatory Triggers
Immunology
Histopathology
Section 4: Symptoms and Respective Interventions
Fatigue
Heat Sensitivity
Muscle Weakness and Mobility Impairment
Muscle Spasticity
Urinary Dysfunction
Bowel Dysfunction
Acute Exacerbations
Section 5: Diagnosis
Pushing the Pause Button: Newly Diagnosed
Deciphering the Diagnosis
Classification
Diagnostic Algorithm
The McDonald Criteria
Section 6: Treating the Underlying Disease
Overview
CIS
DMTs for MS
Progressive MS
Acute Relapse of MS
Investigational Treatment Options
MS Treatments and Vaccines
Section 7: Clinical Vignette
Section 8: Conclusion
Course Summary
Course Contributors
Resources
References
Subject Matter Expert: Elizabeth Vaccaro, BSN RNShalla is a subject matter expert (SME)/writer for Relias. She completed her BSN and two undergraduate degrees with top honors from the University of Wisconsin-Madison. Shalla earned her dual MSN degrees from Johns Hopkins University with top honors. She also maintains her post-baccalaureate nurse educator certificate (NE-BC). Shalla’s tenure spans over 20 years of cross-functional leadership and direct clinical roles in healthcare, biopharma/biotech, government affairs, managed care/market access, nonprofit patient advocacy, and research. Her subject matter expertise is in rare, orphan, and complex diseases. Her sub-expertise is in immune-mediated diseases (rheumatology and immunology), genetics, neurology, hematology/oncology, several pediatric diseases, population/public health, and larger systemic healthcare affairs. Shalla is a published author with leading rare disease experts and a global speaker. She also sits on scientific, advocacy, and legislative advisory boards. She has led national advocacy and disease awareness campaigns, including speaking before congress, leading to the first-in-class rare disease biologic approval and investigative treatment protocols.
Elizabeth Vaccaro earned her Bachelor of Science in nursing from Kean University. She has worked as a Multiple Sclerosis Nurse Educator. Elizabeth has worked in a variety of healthcare settings from the hospital to the pharmaceutical industry which has allowed her to have a great appreciation for all the challenges that span the healthcare field. She has practiced in the hospice setting for nine years in a variety of roles from Case Manager, Educator, and Director of both inpatient and home care hospice.
The target audience for this course is: Nurses; Physicians; in the following settings: Acute Care Facility.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
